Clinical Trial Update: Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients [Phase 1]

View source ↗

Summary

Phase I open-label dose-escalation study to evaluate the safety of iHIVARNA-01 in chronically HIV-infected patients. Results from the study have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• iHIVARNA-01

Snippet

Sponsor: Judit Pich Martínez | Conditions: HIV-infection | Phase 1 | Status: COMPLETED | Results posted: 2025-08-22